These SDH gene alterations, which lead to the loss of enzyme activity and expression, are also observed frequently in several tumors such as renal cell carcinoma, gastrointestinal stromal tumors, colorectal cancer, gastric cancer, and ovarian cancer [7–16]. This evidence concerns the gene SDHB and renal cell carcinoma.